|
Current Status:
|
|
Consultative and interventional cardiology, 1987 to present
|
|
Interventionalist for large cardiology practice. Practice includes atherectomy,
Excimer laser, stent angioplasty.
|
|
|
|
Specialty Certification:
|
|
Certified American Board of Internal Medicine, 1985
|
|
Certified Subspecialty of Cardiovascular Disease, 1993
|
|
|
|
Academic Appointments:
|
|
Assistant Clinical Professor of Medicine, UCLA
|
|
|
|
Licensure:
|
|
California and Iowa
|
|
|
|
Education:
|
|
1976
Government Medical College
South Gujarat University
India
|
|
1971
Pre-Medical School
South Gujarat University
India
|
|
|
|
Postgraduate Training:
|
|
1985-875
Invasive and Non-invasive Cardiology
El Centro, California
|
|
1983-85
Fellowship in Cardiology
Columbus Hospital
Chicago, IL
|
|
1982-83
Emergency Room Physician
Galesburg Cottage Hospital
Galesburg, Illinois
|
|
1979-82
Residency in Internal Medicine
Edgewater Hospital
Chicago, IL
|
|
1978-79
Residency, General Practice
St. Elizabeth Hospital
Chicago, IL
|
|
1976-77
Rotating Internship
University Affiliated Hospitals
Surat, India
|
|
|
|
Professional Memberships:
|
|
Fellow American College of Cardiology, 1994
|
|
American Medical Association, Member
|
|
California Medical Association, 1992
|
|
Kern County Medical Society, 1992
|
|
|
|
Publications:
|
|
Sharma S, Makkar RR, Bhambi B, Nyitray W, Desai K, Ishimori T. Intragraft
administration of abciximab and verapamil combined with direct stenting
prevents slow-flow and no-reflow phenomena in saphenous vein graft percutaneous
coronary interventions. Catheter Cardiovasc Interv 2005; 65 B:119.B 43
(abstract).
|
|
Sharma S, Bhambi B, Nyitray W, Desai K, Davis D, Sharma G, Shukla P, File C,
Ishimori T. Bivalirudin (Angiomax) use during intracoronary brachytherapy may
predispose to acute closure. J Cardiovasc Pharmacol Ther 2003; 8:9-15.
|
|
Sharma S, Bhambi B, Nyitray W, Desai K, Sharma G, Shukla P, Antonescu A, Denny
E, Richardson K, Sadberry R, Ishimori T. Intragraft administration of abciximab
and verapamil combined with direct stenting prevents slow-flow during saphenous
vein graft percutaneous coronary interventions. Am J Cardiol 2002; 154 H.
|
|
|
|
DISCLAIMER: This web site and information is provided for general information
only and is not a substitute for professional medical advice. We are not
responsible or liable for any diagnosis or action made by a user based on the
content of this web site. |
© 2004 Central Cardiology Medical Clinic. All Rights Reserved. |
Tetsuo Ishimori, MD
